macitentan
Actelion boosted by trial success
April 30, 2012Research and Development, Sales and Marketing Actelion, Tracleer, almorexant, macitentan
Actelion’s pulmonary arterial hypertension drug macitentan has met its primary endpoint in a Phase III trial. The news comes after …
Latest content
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
